Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ABIO | ARCA biopharma, Inc.

Index	-	P/E	-	EPS (ttm)	-0.44	Insider Own	18.50%	Shs Outstand	14.41M	Perf Week	1.99%
Market Cap	29.70M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	14.26M	Perf Month	0.00%
Income	-6.30M	PEG	-	EPS next Q	-	Inst Own	38.60%	Short Float / Ratio	1.70% / 10.96	Perf Quarter	-2.38%
Sales	-	P/S	-	EPS this Y	50.40%	Inst Trans	11.35%	Short Interest	0.24M	Perf Half Y	-2.84%
Book/sh	2.72	P/B	0.75	EPS next Y	-	ROA	-14.80%	Target Price	-	Perf Year	-11.06%
Cash/sh	2.77	P/C	0.74	EPS next 5Y	-	ROE	-15.40%	52W Range	1.85 - 2.70	Perf YTD	-13.50%
Dividend	-	P/FCF	-	EPS past 5Y	53.60%	ROI	-	52W High	-24.07%	Beta	1.28
Dividend %	-	Quick Ratio	25.40	Sales past 5Y	-	Gross Margin	-	52W Low	10.81%	ATR	0.04
Employees	5	Current Ratio	25.40	Sales Q/Q	-	Oper. Margin	-	RSI (14)	51.00	Volatility	1.75% 1.79%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	53.00%	Profit Margin	-	Rel Volume	0.67	Prev Close	2.06
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Jul 21 AMC	Payout	-	Avg Volume	22.09K	Price	2.05
Recom	-	SMA20	0.13%	SMA50	0.33%	SMA200	-3.23%	Volume	14,866	Change	-0.49%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-27-18	Initiated	Ascendiant Capital Markets	Buy	$2
Oct-09-13	Initiated	Dawson James	Buy	$3.75

Jul-21-23 04:25PM	ARCA biopharma Announces Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-13-23 11:30AM	We're Not Very Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate (Simply Wall St.)
Apr-24-23 04:25PM	ARCA biopharma Announces First Quarter 2023 Financial Results (GlobeNewswire)
Feb-24-23 04:20PM	ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-03-23 10:19AM	Here's Why We're Not Too Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Situation (Simply Wall St.)
04:05PM	Loading…
Dec-19-22 04:05PM	James Flynn Joins ARCA biopharma Board of Directors (GlobeNewswire)
Nov-14-22 09:24AM	One ARCA biopharma, Inc. (NASDAQ:ABIO) insider upped their stake by 5,155% in the previous year (Simply Wall St.)
Oct-28-22 04:15PM	ARCA biopharma Announces Third Quarter 2022 Financial Results (GlobeNewswire)
Aug-02-22 04:15PM	ARCA biopharma Announces Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-18-22 06:14AM	Is ARCA biopharma (NASDAQ:ABIO) In A Good Position To Deliver On Growth Plans? (Simply Wall St.)
Jun-21-22 04:05PM	Jacob Ma-Weaver Joins ARCA biopharma Board of Directors (GlobeNewswire)
May-05-22 04:15PM	ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review (GlobeNewswire) -5.79%
May-02-22 04:15PM	ARCA biopharma Announces First Quarter 2022 Financial Results (GlobeNewswire)
Apr-18-22 04:30PM	ARCA biopharma Establishes Special Committee of the Board of Directors (GlobeNewswire)
Apr-05-22 01:35AM	Albioma : Governance changes (GlobeNewswire)
07:09AM	Loading…
Apr-01-22 07:09AM	ARCA biopharma's Tissue Factor Inhibitor Disappoints In Mid-Stage COVID-19 Study (Benzinga)
Mar-31-22 04:15PM	ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2b Clinical Trial (GlobeNewswire)
Mar-14-22 04:15PM	ARCA biopharma Announces 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-07-22 04:30PM	Battalion Oil Corporation Announces Fourth Quarter and Full Year 2021 Financial and Operating Results (GlobeNewswire)
Feb-08-22 04:21AM	We're Keeping An Eye On ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate (Simply Wall St.)
Jan-04-22 08:30AM	Data on Gencaro Impact on Prevention of Bradycardia Published in Heart Rhythm O2 (GlobeNewswire)
Dec-02-21 08:30AM	ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19 (GlobeNewswire)
Nov-20-21 07:01AM	ClearPoint Neuro (NASDAQ:CLPT) shareholders are still up 635% over 3 years despite pulling back 13% in the past week (Simply Wall St.)
Nov-09-21 04:15PM	ARCA biopharma to Present at the Q4 Virtual Investor Summit on November 17th (GlobeNewswire)
Nov-02-21 04:15PM	ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-29-21 07:03AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
06:26AM	ARCA Biopharma Stock Gains As Safety Committee Recommends COVID-19 Trial To Continue Unchanged (Benzinga)
Oct-28-21 04:30PM	ASPEN-COVID-19 Data and Safety Monitoring Committee Recommends Continuing Phase 2b Clinical Trial to Completion Based on Interim Analysis of Efficacy and Safety Data (GlobeNewswire)
Sep-16-21 08:30AM	ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19 (GlobeNewswire)
Aug-16-21 08:05AM	ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th (GlobeNewswire) -5.14%
01:15AM	Loading…
Aug-12-21 01:15AM	We Think ARCA biopharma (NASDAQ:ABIO) Can Afford To Drive Business Growth (Simply Wall St.)
Aug-09-21 08:00AM	ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2 (GlobeNewswire)
Aug-04-21 04:15PM	ARCA biopharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-28-21 08:00AM	Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Circulation: Arrhythmia and Electrophysiology (GlobeNewswire)
Jul-13-21 08:00AM	ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19 (GlobeNewswire) -14.09%
Jul-09-21 08:00AM	ARCA biopharma to Present at Access to Giving Virtual Investor Conference on July 13th (GlobeNewswire) +5.75%
Jul-08-21 11:20AM	50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021 (ACCESSWIRE) -6.95%
Jul-07-21 08:00AM	ARCA biopharma Announces rNAPc2 COVID-19 Patent Assignment Agreement (GlobeNewswire) +9.36%
Jun-23-21 09:35AM	50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021 (ACCESSWIRE)
May-11-21 04:15PM	ARCA biopharma Announces First Quarter 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
May-05-21 04:05PM	Christopher Graybill Joins ARCA as Vice President, Clinical Development (GlobeNewswire)
May-03-21 04:30PM	ARCA biopharma Announces C. Jeff Dekker to be Appointed Chief Financial Officer (GlobeNewswire)
Mar-18-21 04:30PM	ARCA biopharma Announces 2020 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-13-21 01:09AM	Here's Why We're Not Too Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Situation (Simply Wall St.)
Dec-15-20 08:30AM	ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 (AB201) as a Potential Treatment for COVID-19 (GlobeNewswire)
Dec-09-20 05:40PM	ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders (GlobeNewswire)
Nov-23-20 12:28PM	ARCA Biopharma gets Fast Track designation for experimental COVID-19 treatment (MarketWatch) +7.46%
08:30AM	AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track Designation (GlobeNewswire)
Nov-02-20 08:30AM	ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update (GlobeNewswire) +5.19%
Oct-07-20 08:30AM	ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19 (GlobeNewswire) -8.49%
Oct-05-20 04:30PM	ARCA biopharma Announces Promotion of Chief Medical Officer and Vice President, Regulatory Affairs & Quality (GlobeNewswire)
Sep-21-20 08:00AM	ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19 (GlobeNewswire) -10.62%
Aug-17-20 08:49AM	We Think ARCA biopharma (NASDAQ:ABIO) Can Afford To Drive Business Growth (Simply Wall St.)
Aug-12-20 08:00AM	ARCA Biopharma Announces Completion of FDA Pre-IND Consultation Under Coronavirus Treatment Acceleration Program for AB201 as a Potential Treatment for Severe COVID-19 (ACCESSWIRE) -7.51%
Aug-05-20 04:15PM	Arca Biopharma Announces Second Quarter 2020 Financial Results and Provides Corporate Update (GlobeNewswire)
Jul-07-20 08:30AM	SARS-CoV-2 Cell Entry Mechanisms in Intact Human Heart Published in JACC: Basic to Translational Science by University of Colorado Anschutz Medical Campus and ARCA biopharma Investigators (GlobeNewswire)
Jun-03-20 09:56AM	ARCA biopharma Announces Closing of $6.1 Million Registered Direct Offering (GlobeNewswire) -5.39%
09:56AM	Biotech Stock Roundup: GILD's Coronavirus Drug Update, NTLA-REGN Deal & More (Zacks)
Jun-01-20 08:20AM	ARCA Biopharma Announces $9.4 Million Registered Direct Offering (GlobeNewswire) -26.98%
May-29-20 12:24PM	A Mighty May: Over $200,000 In Gross Profits (Benzinga) -34.41%
09:59AM	Company News for May 29, 2020 (Zacks)
May-28-20 04:19PM	Arca Biopharma Nearly Quintuples On Plans To Test A Coronavirus Drug (Investor's Business Daily) +386.33%
12:14PM	Arca Biopharma Stock Triples On Plans To Test A Coronavirus Treatment (Investor's Business Daily)
10:27AM	Price Over Earnings Overview: ARCA biopharma (Benzinga)
08:00AM	ARCA biopharma Announces AB201 Development Program for Treatment of COVID-19 Associated Coagulopathy (GlobeNewswire)
May-07-20 08:30AM	Clinical Data Evaluating Gencaro for the Treatment of Atrial Fibrillation in Heart Failure Patients Featured in Three Presentations at the 2020 Heart Rhythm Scientific Sessions (GlobeNewswire)
May-06-20 04:30PM	ARCA Biopharma Announces First Quarter 2020 Financial Results And Provides Corporate Update (GlobeNewswire)
Feb-18-20 04:30PM	ARCA biopharma Announces Fiscal Year 2019 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-01-20 08:31AM	Does Market Volatility Impact ARCA biopharma, Inc.'s (NASDAQ:ABIO) Share Price? (Simply Wall St.)
Nov-06-19 04:10PM	ARCA Biopharma Announces Third Quarter 2019 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-03-19 08:47AM	Is ARCA biopharma (NASDAQ:ABIO) In A Good Position To Invest In Growth? (Simply Wall St.)
Sep-12-19 08:30AM	ARCA Biopharma President and CEO Dr. Michael Bristow to Present at HFSA 2019 Excellence in Translational Science Symposium (GlobeNewswire)
Sep-11-19 08:30AM	Arca Biopharma Announces Gencaro Atrial Fibrillation Clinical Data Selected for Presentation at HFSA 2019 Scientific Meeting (GlobeNewswire) +13.16%
Sep-04-19 01:37PM	Could The ARCA biopharma, Inc. (NASDAQ:ABIO) Ownership Structure Tell Us Something Useful? (Simply Wall St.)
Aug-21-19 09:49AM	INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abiomed, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm (GlobeNewswire) +8.08%
Aug-01-19 04:30PM	ARCA biopharma Announces Second Quarter 2019 Financial Results and Provides Corporate Update (GlobeNewswire) -7.30%
Jun-04-19 07:09AM	One Thing To Remember About The ARCA biopharma, Inc. (NASDAQ:ABIO) Share Price (Simply Wall St.)
May-13-19 09:00AM	ARCA biopharma Announces Submission of Patent Application to U.S. Patent and Trademark Office Covering Treatment of Atrial Fibrillation in Patients With Heart Failure (GlobeNewswire) -10.00%
May-08-19 04:30PM	ARCA Biopharma Announces First Quarter 2019 Financial Results and Provides Corporate Update (GlobeNewswire) +20.03%
May-01-19 08:30AM	GENETIC-AF Phase 2B Trial Results Published in the Journal of American College of Cardiology: Heart Failure (GlobeNewswire) +98.64%
Apr-23-19 08:30AM	ARCA biopharma Announces Steering Committee of Leading International Cardiology and Electrophysiology Experts for PRECISION-AF Phase 3 Clinical Trial (GlobeNewswire)
Mar-18-19 08:30AM	Identification of Phosphodiesterease 3A Polymorphism With Potential to Increase Effectiveness of PDE3 Inhibitors Published in the Journal of the American College of Cardiology (GlobeNewswire)
Mar-06-19 08:00AM	Dose Response of Beta-Blockers in Adrenergic Receptor Polymorphism Genotypes Paper Published in Circulation: Genomic and Precision Medicine (GlobeNewswire)
Feb-27-19 04:15PM	ARCA biopharma Announces Fiscal Year 2018 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-20-19 07:30AM	ARCA Biopharma Announces FDA Agreement for a Single Phase 3 Clinical Trial to Support Approval for the First Genetically-Targeted Cardiovascular Drug (GlobeNewswire) +31.27%
Jan-16-19 08:30AM	Zosano Appoints Linda Grais M.D., J.D. to Board of Directors (GlobeNewswire)
Dec-26-18 11:47AM	ARCA biopharma, Inc. (NASDAQ:ABIO) Insiders Have Been Selling (Simply Wall St.) -7.06%
Dec-20-18 04:01PM	ARCA biopharma Updates Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial (GlobeNewswire) -25.26%
Nov-14-18 04:30PM	ARCA biopharma Announces Third Quarter 2018 Financial Results and Provides Corporate Update (GlobeNewswire) -6.94%
Nov-12-18 08:30AM	GENETIC-AF Phase 2B Clinical Trial Atrial Fibrillation Burden (AFB) Results Presented at American Heart Association 2018 Scientific Sessions (GlobeNewswire)
Nov-05-18 08:30AM	ARCA Biopharma announces phase 2B GENETIC-AF atrial fibrillation burden (AFB) results selected for presentation at american heart association 2018 scientific sessions (GlobeNewswire) +13.17%
Oct-10-18 04:16PM	Westminster biotech company receives second extension on delisting notice from Nasdaq (American City Business Journals) -5.43%
Oct-02-18 08:00AM	Today's Research Reports on Trending Tickers: ARCA biopharma and Nektar Therapeutics (ACCESSWIRE) -35.29%
Sep-18-18 08:30AM	ARCA biopharma Submits Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial (GlobeNewswire)
Aug-09-18 04:15PM	ARCA biopharma Announces Second Quarter 2018 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-03-18 09:45AM	Marijuana Stocks: Biotech Stock Report: 3 Companies To Watch In August 2018 (ACCESSWIRE)
Jul-31-18 12:15PM	3 Biotech Stocks in Focus on Tuesday (ACCESSWIRE)
08:30AM	ARCA Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting With FDA on Gencaro Development for Atrial Fibrillation (GlobeNewswire)
08:10AM	Todays Research Reports on Stocks to Watch: Progenics Pharmaceuticals and Arca Biopharma (ACCESSWIRE)
Jun-19-18 07:05AM	Breakfast Technical Briefing on Alkermes and Three Other Additional Biotech Stocks (ACCESSWIRE)

ARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. It is also developing Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. The company was founded in 2004 and is headquartered in Westminster, Colorado.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABIO | ARCA biopharma, Inc.

Upgrade your FINVIZ experience